Drug pricing experts say CVS' CostVantage program appears designed to pad CVS' own bottom line rather than make drugs cheaper for patients and employers.
The justices' questions reflected the tension between the practical effect of unraveling the settlement and broader concerns about whether the Sacklers should be granted such wide-ranging immunity.